Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence rates following surgical intervention posing ...
A new noninvasive test may be able to detect bladder cancer recurrence earlier than standard cytology and cystoscopy, according to new findings published online July 7 in the British Journal of Cancer ...
New Delhi: Bladder cancer remains one of the most common urological cancers, yet early detection and monitoring of recurrence continue to challenge clinicians. New research now points to measurable ...
Some people can manage a prolapsed bladder, or cystocele, with conservative treatments and without surgery. If a prolapse does not cause problems or block urine flow, it is unlikely to require surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results